The latest immunotherapy news and developments
In the last decade, scientists discovered that blocking a key regulator of the immune system…
The immunotherapy drug blinatumomab significantly improved survival in children with relapsed B-acute lymphoblastic leukaemia (B-ALL)…
Promising pre-clinical results using a bispecific T-cell engager (BiTE), an experimental immunotherapy agent to attack…
A new analysis of Medicare claims data provides the first real-world evidence using claims data…
Research on immune cells “exhausted” by chronic viral infection provides clues on how to refine…
Some men with advanced prostate cancer who have exhausted all other treatment options could live…
Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves overall…
Scientists from the Case Western Reserve University digital imaging lab, already pioneering the use of…
Immunotherapy is better than standard ‘extreme’ chemotherapy as first-line treatment for advanced head and neck…
Piyush K. Jain, University of Florida For the first time in the United States, a…